CAMTEK LTD.
(Registrant) By: /s/ Moshe Eisenberg —————————————— Moshe Eisenberg, Chief Financial Officer |
Camtek Ltd.
P.O.Box 544, Ramat Gabriel Industrial Park
Migdal Ha’Emek 23150, ISRAEL
Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523
E-Mail: Info@camtek.com Web site: http://www.camtek.com
|
|||
CAMTEK LTD.
Moshe Eisenberg, CFO
Tel: +972 4 604 8308
Mobile: +972 54 900 7100
moshee@camtek.com
|
INTERNATIONAL INVESTOR RELATIONS
GK Investor Relations
Ehud Helft/Gavriel Frohwein
Tel: (US) 1 646 688 3559 camtek@gkir.com
|
· |
Revenues were a record at $32.3 million, up 35% year-over-year and ahead of the upper-end of the previously issued guidance range of $31-32 million;
|
· |
GAAP gross margin was 50.2%; Non-GAAP gross margin was 50.4%;
|
· |
GAAP operating income was $5.6 million and non-GAAP operating income was $6.2 million, representing margins of 17.2% and 19.2%, respectively;
|
· |
GAAP net income of $5.1 million or $0.14 per diluted share and non-GAAP net income of $5.7 million or $0.16 per diluted share, representing year-over-year growth of 84% and 100%, respectively and;
|
· |
Operating cash flow of $7.1 million;
|
US:
|
1 888 668 9141
|
at 9:30 am Eastern Time
|
|
Israel:
|
03 918 0609
|
at 3:30 pm Israel Time
|
|
International:
|
+972 3 918 0609
|
|
September 30,
|
December 31,
|
|||||||
2018
|
2017
|
|||||||
U.S. Dollars (In thousands)
|
||||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
48,328
|
43,744
|
||||||
Trade accounts receivable, net
|
30,746
|
23,153
|
||||||
Inventories
|
25,789
|
21,336
|
||||||
Other current assets
|
3,536
|
3,215
|
||||||
Total current assets
|
108,399
|
91,448
|
||||||
Fixed assets, net
|
15,798
|
15,503
|
||||||
Long-term inventory
|
1,799
|
1,383
|
||||||
Deferred tax asset
|
2,890
|
4,067
|
||||||
Other assets, net
|
153
|
153
|
||||||
Intangible assets, net
|
508
|
482
|
||||||
5,350
|
6,085
|
|||||||
Total assets
|
129,547
|
113,036
|
||||||
Liabilities and shareholders’ equity
|
||||||||
Current liabilities
|
||||||||
Trade accounts payable
|
13,746
|
10,502
|
||||||
Other current liabilities
|
20,127
|
17,395
|
||||||
Total current liabilities
|
33,873
|
27,897
|
||||||
Long term liabilities
|
||||||||
Liability for employee severance benefits
|
873
|
838
|
||||||
873
|
838
|
|||||||
Total liabilities
|
34,746
|
28,735
|
||||||
Shareholders’ equity
|
||||||||
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at September 30, 2018 and at December 31, 2017;
|
||||||||
38,526,231 issued shares at September 30, 2018 and 37,924,507 at December 31, 2017;
|
||||||||
36,433,855 shares outstanding at September 30, 2018 and 35,832,131 at December 31, 2017
|
151
|
149
|
||||||
Additional paid-in capital
|
81,040
|
78,437
|
||||||
Retained earnings
|
15,508
|
7,613
|
||||||
96,699
|
86,199
|
|||||||
Treasury stock, at cost (2,092,376 as of September 30, 2018 and December 31, 2017)
|
(1,898
|
)
|
(1,898
|
)
|
||||
Total shareholders' equity
|
94,801
|
84,301
|
||||||
Total liabilities and shareholders' equity
|
129,547
|
113,036
|
Nine Months ended
September 30,
|
Three Months
ended September 30,
|
Year ended
December 31,
|
||||||||||||||||||
2018
|
2017
|
2018
|
2017
|
2017
|
||||||||||||||||
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
Revenues
|
90,000
|
67,641
|
32,264
|
23,813
|
93,485
|
|||||||||||||||
Cost of revenues
|
45,921
|
34,447
|
16,081
|
12,063
|
47,966
|
|||||||||||||||
Gross profit
|
44,079
|
33,194
|
16,183
|
11,750
|
45,519
|
|||||||||||||||
Research and development costs
|
10,456
|
10,067
|
3,501
|
3,215
|
13,534
|
|||||||||||||||
Selling, general and administrative expenses
|
19,792
|
16,847
|
7,128
|
5,688
|
22,022
|
|||||||||||||||
Patent litigation expense
|
-
|
13,000
|
-
|
-
|
13,000
|
|||||||||||||||
Total operating expenses
|
30,248
|
39,914
|
10,629
|
8,903
|
48,556
|
|||||||||||||||
Operating income (loss)
|
13,831
|
(6,720
|
)
|
5,554
|
2,847
|
(3,037
|
)
|
|||||||||||||
Financial income (expenses), net
|
491
|
(199
|
)
|
55
|
10
|
(150
|
)
|
|||||||||||||
Income (loss) from continuing operations
|
||||||||||||||||||||
before income taxes
|
14,322
|
(6,919
|
)
|
5,609
|
2,857
|
(3,187
|
)
|
|||||||||||||
Income tax benefit (expense)
|
(1,364
|
)
|
5,281
|
(516
|
)
|
(83
|
)
|
4,875
|
||||||||||||
Income (loss) from continuing operations
|
12,958
|
(1,638
|
)
|
5,093
|
2,774
|
1,688
|
||||||||||||||
Discontinued operation
|
||||||||||||||||||||
Income from discontinued operation
|
||||||||||||||||||||
Income before tax benefit (expense)
|
-
|
18,302
|
-
|
13,963
|
18,302
|
|||||||||||||||
Income tax benefit (expense)
|
-
|
(5,563
|
)
|
-
|
(5,058
|
)
|
(6,028
|
)
|
||||||||||||
Income from discontinued operation
|
-
|
12,739
|
-
|
8,905
|
12,274
|
|||||||||||||||
Net income
|
12,958
|
11,101
|
5,093
|
11,679
|
13,962
|
|||||||||||||||
Net income (loss) per ordinary share:
|
||||||||||||||||||||
Basic earnings (loss) from continuing operation
|
0.36
|
(0.05
|
)
|
0.14
|
0.08
|
0.05
|
||||||||||||||
Basic earnings from discontinued operation
|
-
|
0.36
|
-
|
0.25
|
0.35
|
|||||||||||||||
Diluted earnings (loss) from continuing operation
|
0.35
|
(0.05
|
)
|
0.14
|
0.08
|
0.05
|
||||||||||||||
Diluted earnings from discontinued
|
||||||||||||||||||||
operation
|
-
|
0.35
|
-
|
0.24
|
0.34
|
|||||||||||||||
Weighted average number of
|
||||||||||||||||||||
ordinary shares outstanding:
|
||||||||||||||||||||
Basic
|
36,105
|
35,374
|
36,300
|
35,404
|
35,441
|
|||||||||||||||
Diluted
|
36,657
|
35,972
|
36,941
|
36,361
|
35,964
|
Nine Months ended
September 30,
|
Three Months ended
September 30,
|
Year ended
December 31,
|
||||||||||||||||||
2018
|
2017
|
2018
|
2017
|
2017
|
||||||||||||||||
U.S. dollars
|
U.S. dollars
|
U.S. dollars
|
||||||||||||||||||
Reported net income (loss) attributable to Camtek Ltd. on GAAP basis
|
12,958
|
11,101
|
5,093
|
11,679
|
13,962
|
|||||||||||||||
Effect of FIT reorganization (1)
|
506
|
-
|
-
|
-
|
-
|
|||||||||||||||
Share-based compensation
|
1,028
|
276
|
634
|
92
|
426
|
|||||||||||||||
Settlement expense, net of tax (2)
|
-
|
12,025
|
-
|
-
|
12,025
|
|||||||||||||||
Realization of deferred tax assets (3)
|
-
|
(4,495
|
)
|
-
|
-
|
(4,495
|
)
|
|||||||||||||
Attributable to discontinued operations
|
-
|
(12,739
|
)
|
-
|
(8,905
|
)
|
(12,274
|
)
|
||||||||||||
Non-GAAP net income
|
14,492
|
6,168
|
5,727
|
2,866
|
9,644
|
|||||||||||||||
Non –GAAP diluted net income per share
|
0.40
|
0.17
|
0.16
|
0.08
|
0.27
|
|||||||||||||||
Gross margin on GAAP basis from continuing operations
|
49.0
|
%
|
49.1
|
%
|
50.2
|
%
|
49.3
|
%
|
48.7
|
%
|
||||||||||
Reported gross profit on GAAP basis
|
44,079
|
33,194
|
16,183
|
11,750
|
45,519
|
|||||||||||||||
Effect of FIT reorganization (1)
|
205
|
-
|
-
|
-
|
-
|
|||||||||||||||
Share-based compensation
|
105
|
28
|
62
|
9
|
44
|
|||||||||||||||
Non- GAAP gross margin
|
44,389
|
33,222
|
16,245
|
11,759
|
45,563
|
|||||||||||||||
Non-GAAP gross profit
|
49.3
|
%
|
49.1
|
%
|
50.4
|
%
|
49.4
|
%
|
48.7
|
%
|
||||||||||
Reported operating income (loss) attributable to Camtek Ltd. on GAAP basis from continuing operations
|
13,811
|
(6,720
|
)
|
5,554
|
2,847
|
(3,037
|
)
|
|||||||||||||
Effect of FIT reorganization (1)
|
506
|
-
|
-
|
-
|
-
|
|||||||||||||||
Share-based compensation
|
1,028
|
276
|
634
|
92
|
426
|
|||||||||||||||
Settlement expense (2)
|
-
|
13,000
|
-
|
-
|
13,000
|
|||||||||||||||
Non-GAAP operating income
|
15,365
|
6,556
|
6,188
|
2,939
|
10,389
|
(1) |
At the end of the first quarter of 2018, the Company ceased its efforts to utilize the remaining inventory and equipment related to FIT development and recorded a one-time write-off in the amount of $0.5 million, consisting of: (1) inventory write-offs of $0.2 million, recorded under the cost of revenue line item; and (2) fixed asset write-offs of $0.3 million recorded under operating expenses.
|
(2) |
During the three and the nine months ended September 30, 2017, and the year ended December 31, 2017, the Company recorded a provision of $13 million ($12 million net of tax) in conjunction settlement with Rudolph Technologies Inc.
|
(3) |
During the three and the nine months ended September 30, 2017, and the year ended December 31. 2017, the Company recorded net income of $4.5 million as a result of a decrease in the valuation allowance on deferred tax assets following the evaluation of the realizability of the assets based on projected future earnings.
|